Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Anders Nissen Bonde

Roskilde University Hospital, Roskilde (Denmark)

27 More presentations in this session

Presentation thumbnail

The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis.

Professor P. Penson (Liverpool, GB)

Abstract Slides

Presentation thumbnail

Net clinical benefit of NOACs vs. VKAs in elderly patients with atrial fibrillation: a pooled analysis from the real-world PREFER in AF and PREFER in AF PROLONGATION registries

Doctor I. Cavallari (Rome, IT)

Abstract Slides

Presentation thumbnail

A meta-analysis of efficacy and safety of Watchman device for left atrial appendage closure in non-valvular atrial fibrillation

Doctor A. Jhand (Omaha, US)

Abstract Slides

Presentation thumbnail

A metaanlysis for safety and efficacy of amplatzer cardiac plug and amulet device for left atrial appendage closure in patiets with non valvular atrial fibrillation

Doctor A. Thandra (Omaha, US)

Abstract Slides

Presentation thumbnail

Use of oral anticoagulation is less among hospitalized patients with paroxysmal compared to persistent or permanent atrial fibrillation

Doctor S. Pokorney (Durham, US)

Access the full session

Session thumbnail

Poster Session 4 - Atrial fibrillation - Stroke prevention

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Interactive discussion and Q&A

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

Congress Session

EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources